Source: Annual Congress 2002 - Drug resistance
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. S. Gaidamoniene, E. Aleksaite, P. Butkiene, A. Sosnovskaja, E. Davidaviciene, A. Petraskaite, R. Krikstopaityte (Vilnius, Lithuania). Anti-tuberculosis resistance among tuberculosis relapses in Lithuania. Eur Respir J 2002; 20: Suppl. 38, 2224

Member's Comments

No comment yet.

Related content which might interest you: Tuberculosis 1995–2004: evaluation of the resistance of mycobacterium tuberculosis to anti-TBC drugs in Greece Source: Eur Respir J 2006; 28: Suppl. 50, 589s Year: 2006 Resistance rates of Mycobacterium tuberculosis to first-line antituberculosis drugs. Trends in Greece during the period 1991–2000 Source: Eur Respir J 2003; 22: Suppl. 45, 525s Year: 2003 Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Multi-drug resistance tuberculosis in Greece Source: Eur Respir J 2003; 22: Suppl. 45, 344s Year: 2003 Tuberculosis epidemiology and drug resistance in prisons of Lithuania Source: Eur Respir J 2004; 24: Suppl. 48, 193s Year: 2004 Multi-drug resistant pulmonary tuberculosis in Belarus Source: Annual Congress 2007 - Epidemiology of various lung diseases Year: 2007 Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia Source: Eur Respir J 2012; 40: 133-142 Year: 2012 Mycobacterium tuberculosis drug resistance surveillance in Belarus Source: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005 Multidrug resistance of M. tuberculosis and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 272s Year: 2007 High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of Moldova Source: Eur Respir J, 50 (4) 1701340; 10.1183/13993003.01340-2017 Year: 2017 Treatment outcome of multi-drug resistant tuberculosis in the Republic of Moldova Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 The association between HIV and antituberculosis drug resistance Source: Eur Respir J 2008; 32: 718-725 Year: 2008 Surveillance of M. tuberculosis drug resistance in Russia Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001 Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Bacteriological conversion in XDR-TB and RR-TB patients with fluoroquinolone resistance treated with and without new and repurposed anti-TB drugs in Azerbaijan prisons Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 The prevalence of pyrazinamide resistance in multidrug resistant tuberculosis cases in the Netherlands Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Multidrug resistance influence on tuberculosis mortality and lethal outcome in prisons of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 425s Year: 2007 Multi-drug resistant tuberculosis (MDR-TB) in Ramnicul Valcear, Romania; drug treatment, resistance testing and adverse drug reactions Source: Eur Respir J 2006; 28: Suppl. 50, 378s Year: 2006 Secondary drug resistance tuberculosis in Iran Source: Eur Respir J 2006; 28: Suppl. 50, 586s Year: 2006